03.20.19
Manatt Health’s recent report, “Assessing the Regulatory Burden on Inpatient Psychiatric Facilities,” on inpatient psychiatric facility regulations was detailed in a new article in Modern Healthcare.The study found that inpatient psychiatric facilities across the country face over ...
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke to CNN about partisan disagreements in Congress regarding drug prices.
03.19.19
Manatt’s Cindy Mann, a partner with Manatt Health, spoke to Healthcare Dive on Medicaid work requirements at the National Health Policy Conference 2019, hosted by America’s Health Insurance Plans (AHIP).
03.15.19
Cindy Mann, a partner in Manatt Health, spoke to the Healthcare Financial Management Association about new developments in the push for Medicaid and Medicare to address the social determinants of health.Mann is the former head of the Medicaid office at the Centers for Medicare & Medicaid ...
02.25.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with CNBC ahead of a Senate Finance Committee hearing on February 26 in which CEOs from seven of the country’s largest pharmaceutical companies provided testimony about drug pricing in the U.S.
02.14.19
Manatt’s Cindy Mann, a partner with Manatt Health, spoke to Connecticut News Junkie about government-sponsored public health insurance options in the state.
02.01.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke to FierceHealthcare about the government potentially ending safe-harbor protections for drug rebates in commercial insurance.
Deborah Bachrach, a partner in Manatt Health, spoke to the Birmingham Business Journal about potential expansion of Alabama’s Medicaid program.
Manatt’s Patricia Boozang, a senior managing director at Manatt Health, spoke with Modern Healthcare about a new Medicaid expansion bill in Utah.State senate Republicans in Utah are seeking to replace voter-approved Medicaid expansion with a bill that includes a cap on federal payments and a ...
01.23.19
Manatt’s Adam Finkelstein, a counsel with our Manatt Health group, was interviewed by Healthcare Financial Management to discuss Medicare’s expansion of its value-based insurance design (VBID) model and its plans to create a new drug plan model.